| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06.07 | Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer | 70 | PR Newswire | CHICAGO, June 2 /PRNewswire/ --
- Study Highlights Quality-of-Life Data
ALIMTA(R) (pemetrexed for injection) showed additional utility in the
treatment of the most diagnosed type of... ► Artikel lesen | |
| 02.06.07 | Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting | 58 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Pharmion Corporation and MethylGene Inc. (TSX: MYG) today announced preliminary Phase II and Phase I/II data for their lead oncology product candidate, MGCD0103... ► Artikel lesen | |
| 02.06.07 | Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer | 24 | PR Newswire | CHICAGO, June 2 /PRNewswire/ --
- Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR
GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with
paclitaxel... ► Artikel lesen | |
| 02.06.07 | Genomic Health, Inc. Announces Oncotype DX Recurrence Score Influences Treatment Decisions for Physicians and Patients in Prospective Study | 28 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced results of an independent prospective multi-center study indicating that the Oncotype DX Recurrence Score changes treatment... ► Artikel lesen | |
| 02.06.07 | Study Presented at ASCO Shows Encouraging Preliminary Results for Phase II Trial of OGX-011 in Advanced Prostate Cancer | 40 | PR Newswire | VANCOUVER and CARLSBAD, CA, June 2 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. today announced preliminary data from a Phase II clinical trial of OGX-011 in... ► Artikel lesen | |
| 02.06.07 | Clinical Data Presented on Pilot Pharmacokinetic Study of Oral Azacitidine | 180 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Pharmion Corporation today reported data from a pilot study that demonstrated the bioavailability of the Company's oral dosage formulation of Azacitidine.... ► Artikel lesen | |
| 02.06.07 | Results of VEGF Trap (Aflibercept) Highlighted at ASCO 2007 Annual Meeting | 24 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. today announced encouraging preliminary results from two Phase II studies... ► Artikel lesen | |
| 02.06.07 | Crest Toothpaste Safe | 24 | PR Newswire | CINCINNATI, June 2 /PRNewswire-FirstCall/ -- The Procter & Gamble Company's Crest toothpaste brand is not affected by the FDA import and health alert. Crest does not import toothpaste manufactured... ► Artikel lesen | |
| 02.06.07 | Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer | 17 | PR Newswire | CHICAGO, June 2 /PRNewswire/ --
- Study Supports Lilly's Commitment to Advances in Lung Cancer Treatment
Enzastaurin, an investigational targeted, oral agent under development by
Eli... ► Artikel lesen | |
| 02.06.07 | Data Presented at ASCO Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma | 17 | PR Newswire | COLLEGEVILLE, Pa., June 2 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth , today presented two analyses of the phase 3 clinical trial of TORISEL(TM) (temsirolimus) for the treatment of... ► Artikel lesen | |
| 02.06.07 | Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival | 24 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Long-term treatment with pegylated interferon alfa-2b in stage III melanoma had a significant and sustained impact on relapse-free survival (RFS), according... ► Artikel lesen | |
| 02.06.07 | Exelixis Reports Comprehensive XL880 Phase I Data At ASCO | 19 | PR Newswire | CHICAGO, June 2 /PRNewswire-FirstCall/ -- Exelixis, Inc. reported data from the Phase I clinical trial program for XL880, a novel small molecule compound that simultaneously inhibits MET and VEGFR2... ► Artikel lesen | |
| 02.06.07 | Masisa S.A. Agrees to Sell 90% of Forestal Argentina S.A. and to Create an Association with New Shareholders | 37 | PR Newswire | SANTIAGO, Chile, June 2 /PRNewswire-FirstCall/ -- MASISA S.A. (hereinafter referred to as "Masisa" or "the Company"). Masisa announced today that it signed a binding agreement for the sale of 90%... ► Artikel lesen | |
| 02.06.07 | ECC Capital Corporation Reports Results for Fourth Quarter and Year Ended December 31, 2006 | 9 | PR Newswire | IRVINE, Calif., June 1 /PRNewswire-FirstCall/ -- ECC Capital Corporation (BULLETIN BOARD: ECROE) , a mortgage finance real estate investment trust (REIT) that invests in residential mortgage loans... ► Artikel lesen | |
| 02.06.07 | DME Has Successful Launch; Trades More Than 2,800 Contracts on Opening Day | 14 | PR Newswire | NEW YORK, June 1 /PRNewswire-FirstCall/ -- The New York Mercantile Exchange, Inc., a subsidiary of NYMEX Holdings, Inc. , today announced that the Dubai Mercantile Exchange (DME) enjoyed a robust opening... ► Artikel lesen | |
| 02.06.07 | U.S. Geothermal Announces Increase to Stock Option Exercise Prices to Comply With U.S. Internal Revenue Code Requirements | 77 | PR Newswire | BOISE, Idaho, June 1 /PRNewswire-FirstCall/ -- (BULLETIN BOARD: UGTH, TSX.V: GTH) U.S. Geothermal Inc. (the "Company") announced today that in March 2007 it entered into option repricing agreements... ► Artikel lesen | |
| 02.06.07 | Atmel Announces Certified Results for Special Meeting | 14 | PR Newswire | SAN JOSE, Calif., June 1 /PRNewswire-FirstCall/ -- Atmel(R) Corporation today announced that the results from the Company's May 18, 2007 special meeting have been tabulated and certified by the independent... ► Artikel lesen | |
| 02.06.07 | Global Med Technologies(R), Inc. Files Post Effective Amendment Related to Previously Registered Shares | 19 | PR Newswire | DENVER, June 1 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (BULLETIN BOARD: GLOB) , today announced that it has filed a post effective amendment related... ► Artikel lesen | |
| 02.06.07 | UTStarcom Concludes Strategic Alternatives Process | 20 | PR Newswire | ALAMEDA, Calif., June 1 /PRNewswire-FirstCall/ -- UTStarcom, Inc. , a global leader in IP-based, end-to-end networking solutions and services, today announced that the special committee of the company's... ► Artikel lesen | |
| 02.06.07 | CMS Energy Subsidiaries Reach Agreements to Sell GasAtacama of Chile and Jamaica Private Power Company Limited for a Combined $94 Million | 19 | PR Newswire | JACKSON, Mich., June 1 /PRNewswire-FirstCall/ -- CMS Energy subsidiaries have entered into an agreement to sell their interests in GasAtacama of Chile and a separate agreement to sell their interests... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 2.155 |
| TUI | 1.765 |
| SUPER MICRO COMPUTER | 1.665 |
| RHEINMETALL | 1.514 |
| TESLA | 1.355 |
| NEL | 1.203 |
| BAYER | 1.176 |
| VARTA | 1.130 |
| RENK GROUP | 965 |
| DEUTSCHE LUFTHANSA | 879 |
| BYD | 811 |
| AIXTRON SE | 777 |
| BASF | 678 |
| DEUTSCHE BANK | 659 |
| NETFLIX | 640 |
| COMMERZBANK | 552 |
| RWE | 530 |
| PLUG POWER | 507 |
| EVOTEC | 504 |
| THYSSENKRUPP | 491 |
| ALLIANZ | 464 |
| BARRICK GOLD | 459 |
| INFINEON | 448 |
| VOLKSWAGEN | 447 |
| MERCEDES-BENZ | 441 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
